DCEG Scientists Present at International Society of Radiation Epidemiology and Dosimetry Meeting
, by Elise Tookmanian, Ph.D.
After the inaugural International Society of Radiation Epidemiology and Dosimetry (ISoRED) meeting was postponed in 2020 due to the COVID-19 pandemic, ISoRED had its first in-person meeting in Sitges, Spain in May 2023. Radiation Epidemiology Branch (REB) investigators were instrumental in the founding of ISoRED. There were many presentations by DCEG investigators, staff scientists, and fellows, which are listed below.
Cari Kitahara, Ph.D. - “The U.S. Radiologic Technologists Study: Cohort updates and opportunities for collaboration”
Keith Griffin, Ph.D. - "Groundwork for a revision of radiation exposure assessments for the Japanese atomic bomb survivors"
Choonsik Lee, Ph.D. - "Organ dose calculation methods and tools for patients undergoing computed tomography, nuclear medicine, and fluoroscopy exams"
Cato Milder, Ph.D., M.S.P.H. - "Lung cancer risk update in the US Radiologic Technologists Cohort: Can we revise sex-specific radiation-related risk estimates at low dose-rates?"
Matthew M. Mille, Ph.D. - “Dose reconstruction for a large-scale retrospective study on late health effects following radiotherapy within the National Wilms Tumor Study”
Lindsay M. Morton, Ph.D. - "Risk of therapy-related subsequent cancers in individuals with germline TP53 variants" and "Genomic characterization of cervical lymph node metastases in papillary thyroid carcinoma following the Chornobyl accident"
Lene H.S. Veiga, Ph.D. - “Thoracic soft tissue sarcoma risk following breast cancer treatment in two US retrospective cohorts"
Vladimir Drozdovitch, Ph.D. - "Dose reconstruction for epidemiological studies among Chernobyl cleanup workers"
Sergio Morato Rafet, Ph.D., M.S. - "Anatomical predictive extension of partial-body CT scans for assessing organ dose in support of epidemiological studies on late effects following radiotherapy"
Sara Schonfeld, Ph.D. - “Changing patterns of irradiation in conditioning regimens for allogeneic hematopoietic cell transplantation (HCT) for hematologic malignancies and implications for subsequent neoplasm (SN) risk: Preliminary analyses within a novel linked dataset of Center For International Blood And Marrow Transplant Research (CIBMTR) and California Cancer Registry (CCR) Data”